What questions should I ask my oncologist about metastatic Brain Cancer

Key Questions to Ask Your Oncologist About Metastatic Brain Cancer

I'm glad you're preparing questions—this is one of the most important things you can do to understand your care. Here are the critical questions organized by topic:

UNDERSTANDING YOUR DIAGNOSIS

1. What is the primary cancer (where did it originate)?

• This matters enormously because treatment depends on the original cancer type. According to the NCCN Guidelines for Central Nervous System Cancers, lung cancer is the most common source of brain metastases, followed by melanoma and breast cancer.

2. How many brain metastases do I have, and where are they located?

• Ask your doctor to show you the imaging and explain the size and location of each lesion. The NCCN Guidelines note that nearly 80% occur in the cerebral hemispheres, 15% in the cerebellum, and 5% in the brainstem—location affects treatment options.

3. What is my performance status (how well am I functioning)?

• This influences which treatments are appropriate for you. Be honest about your symptoms and daily functioning.

TREATMENT OPTIONS & DECISION-MAKING

4. What are ALL my treatment options?

• According to NCCN Guidelines, the main approaches include:
  • Surgery (if the metastasis is accessible and causing significant mass effect)
  • Stereotactic Radiosurgery (SRS) - a focused radiation technique
  • Whole Brain Radiation Therapy (WBRT)
  • Systemic therapy (chemotherapy, immunotherapy, or targeted therapy based on your primary cancer)
  • Combinations of the above

Ask your doctor which options apply to YOUR specific situation.

5. Why do you recommend [specific treatment] for me?

• The NCCN Guidelines show that treatment choice depends on:
  • Number of metastases
  • Size of lesions
  • Whether they're causing symptoms
  • Your overall health and life expectancy
  • Your primary cancer type

6. What is the goal of treatment—cure, control, or symptom relief?

• This is crucial for setting realistic expectations and understanding what "success" means for your situation.

SURGERY (If Recommended)

7. Am I a candidate for surgery? Why or why not?

8. If surgery is recommended, what are the benefits and risks?

• According to NCCN Guidelines, surgery can help with diagnosis, reducing mass effect (swelling/pressure), and improving edema. However, surgery alone has poor local control rates—additional radiation is typically recommended.

9. What happens after surgery—will I need additional radiation?

• The NCCN Guidelines show that post-operative radiation (either SRS or WBRT) significantly reduces recurrence and neurologic death.

RADIATION THERAPY (SRS vs. WBRT)

10. Am I a candidate for Stereotactic Radiosurgery (SRS)?

• SRS is a minimally invasive option that avoids surgery risks. According to NCCN Guidelines, multiple phase III trials show SRS alone provides comparable survival to SRS plus WBRT, but with better cognitive preservation and quality of life.

11. If WBRT is recommended, what are the cognitive side effects I should expect?

• This is important: NCCN Guidelines show that WBRT can cause cognitive decline. Ask about:
  • Timing and severity of potential memory problems
  • Whether hippocampal-sparing techniques are available (these protect memory centers)
  • Long-term quality of life impacts

12. What's the difference between SRS alone vs. SRS plus WBRT for my situation?

• NCCN Guidelines show SRS alone is preferred when possible due to better cognitive outcomes, but your doctor may recommend WBRT based on your specific case.

SYSTEMIC THERAPY (Chemotherapy, Immunotherapy, Targeted Therapy)

13. Based on my primary cancer type, what systemic treatments might work?

• This depends entirely on your original cancer. For example:
  • Melanoma: Immunotherapy combinations (like ipilimumab + nivolumab) or BRAF/MEK inhibitors show good brain penetration
  • Lung cancer: PD-1/PD-L1 inhibitors, ALK inhibitors, or EGFR inhibitors (depending on mutations)
  • Breast cancer: Hormone therapy or HER2-targeted therapy (depending on receptor status)

14. Have you tested my tumor for specific mutations or biomarkers?

• Ask about testing for:
  • PD-L1 status (for immunotherapy eligibility)
  • EGFR mutations (lung cancer)
  • ALK rearrangement (lung cancer)
  • BRAF mutations (melanoma)
  • HER2 status (breast cancer)
  • Other actionable mutations

According to NCCN Guidelines, "basket" studies now evaluate targeted therapies based on specific mutations regardless of tumor type.

15. Can systemic therapy alone treat my brain metastases, or do I need radiation first?

• NCCN Guidelines note that some patients with asymptomatic brain metastases can be treated with systemic therapy upfront instead of immediate SRS or WBRT, but this requires careful monitoring with regular brain MRIs.

MONITORING & FOLLOW-UP

16. How often will I need brain MRIs to monitor my metastases?

• Regular imaging is essential to catch progression early.

17. What symptoms should prompt me to call you immediately?

• Ask about warning signs like severe headaches, vision changes, balance problems, seizures, or neurologic changes.

18. If my current treatment isn't working, what's the next step?

• Discuss backup plans so you're not caught off-guard if treatment needs to change.

CLINICAL TRIALS

19. Are there clinical trials available for my specific situation?

• Ask your doctor about trials testing new combinations or approaches. The Musella Foundation and Cancer Commons maintain registries of brain cancer trials.

20. What are the pros and cons of participating in a clinical trial?

• Understand both the potential benefits and the risks (including possible placebo assignment).

QUALITY OF LIFE & SUPPORT

21. What side effects should I expect, and how will they be managed?

• Ask about steroids (often used to reduce brain swelling), anti-seizure medications, and other supportive care.

22. What resources are available—support groups, neuropsychological testing, rehabilitation?

• Brain cancer treatment can affect cognition and function. Ask about supportive services.

23. Should I get a second opinion?

• This is always reasonable, especially for complex cases. Many oncologists expect and respect this.

---

IMPORTANT CONTEXT FROM EXPERT SOURCES

According to the Musella Foundation's Brain Tumor Guide, when you have brain metastases, it's important to understand that:

• Treatment differs significantly based on whether you have one metastasis or multiple
• The primary cancer type (where it started) determines what systemic therapies might work
• A multidisciplinary team (surgeon, radiation oncologist, medical oncologist) should be involved in planning

The NCCN Guidelines for Central Nervous System Cancers emphasize that treatment decisions should be individualized based on:

• Number and size of metastases
• Symptoms
• Performance status
• Primary cancer type and treatment history
• Life expectancy

---

TIPS FOR YOUR APPOINTMENT

✓ Write these questions down and bring them with you
✓ Bring a family member or friend to help you remember information
✓ Ask your doctor to explain imaging so you understand what you're seeing
✓ Request copies of your pathology report, imaging reports, and any genetic testing results
✓ Take notes or ask if you can record the conversation (with permission)
✓ Don't hesitate to ask for clarification if something doesn't make sense

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.